Human bone marrow (BM) contains a rare population of nonhematopoietic mesenchymal stromal cells (MSCs), which are of central importance for the hematopoietic microenvironment. However, the precise phenotypic definition of these cells in adult BM has not yet been reported. In this study, we show that low/negative expression of CD140a (PDGFR-a) on lin 
INTRODUCTION
Human bone marrow (BM) contains-besides the wellknown hematopoietic stem cells (HSCs)-a population of nonhematopoietic mesenchymal stromal cells (MSCs), which are multipotent and can differentiate toward skeletal lineages in vivo (Sacchetti et al., 2007) . In vitro, clonogenic cells, which are denoted as colony-forming unit-fibroblasts (CFU-Fs) (Friedenstein et al., 1970) , can be assayed from the BM as plastic adherent cells giving rise to fibroblastic colonies. These CFU-F cells are considered to reflect the primary BM-MSC, and upon further proliferation in culture, their descendants make up the extensively studied cultured MSCs (Keating, 2012) .
BM-MSCs are able to generate hematopoietic stroma upon transplantation in vivo, thus providing the specialized microenvironments for HSCs (Sacchetti et al., 2007) . Furthermore, BM-MSCs have been shown to play an important role in regulating self-renewal and differentiation of HSCs (Méndez-Ferrer et al., 2010) , and they have also been implicated in the development of hematological malignancies (Raaijmakers et al., 2010) .
However, the precise in vivo identity and phenotypic signature of adult BM-MSCs have thus far remained elusive (Keating, 2012) . Therefore, this current study aimed for a precise phenotypic characterization of the human BM stromal cell population by utilizing comparative gene expression profiling as a screening tool. Based on this screening, low/negative expression of CD140a (PDGFR-a) was identified as the key feature that enabled the isolation of a close to pure population of primary MSC in adult human BM nonhematopoietic CD271 + cells. In contrast, human fetal BMMSCs were recently reported to be CD140a positive (Pinho et al., 2013) , indicating that PDGFR-a expression is regulated developmentally. (Churchman et al., 2012; Tormin et al., 2011) . Therefore, an array-based gene expression analysis was performed comparing these two cell populations as a screening tool to identify potential MSC surface markers (the sorting strategy is presented in Figure S1 available online). In total, 219 genes were significantly upregulated in the CD271 + subset, including typical MSC genes as well as genes encoding for cytokines, growth factors, and extracellular matrix proteins (Table S1 ). Twenty-eight upregulated genes were related to surfaceexpressed molecules ( Figure 1A ; Table S2 ). Only eight genes were cell surface markers that had been previously reported Stem Cell Reports j Vol. 3 j 965-974 j December 9, 2014 j ª2014 The Authors 965   MME  FCRLA  TGFBR2  BST2  TMEM2  NTRK2  EFNA1  CD151  TMEM119  ABCA9  ITGB2  IL1R1  TMEM98  TGFBR3  GHR  IFNGR2  CNTNAP2  FGFR3  TNFRSF19  PDGFRA  LEPR  VCAM1  TNFRSF1A  CD81  CDH11  PDGFRB  IL11RA  ITGB5 CD45-CD271+ CD45-CD271- (Churchman et al., 2012) ; CD140b, CD10, CD106 (Battula et al., 2008; Bühring et al., 2007; Gronthos et al., 2003) ; and CD140a (Pinho et al., 2013) . The remaining 20 genes, of which four were selected for validation by quantitative RT-PCR confirming the results of the gene array ( Figure 1B) , had not been reported in the context of MSC isolation. Figures 1C and 1D ). TNFR1 was the only candidate gene for which measurable protein expression levels were not detected (data not shown).
RESULTS AND DISCUSSION
Most of the identified markers showed a staining pattern that paralleled CD271 expression; i.e., expression levels of the newly discovered marker increased with increasing CD271 levels (group I markers; Figure 1C ). Therefore, these markers would not be expected to improve CFU-F enrichment in sorted CD271 + cells. Accordingly, experiments using CD151 as an example ( Figure 1C , lower panel), demonstrated that CFU-F frequencies were not significantly different compared with isolation based on CD271 and other known MSC markers, such as CD106 ( Figure 1C , lower panel; Figure S2A ). Figures  S2G-S2I ). LEPR is another group I marker that was recently reported to identify the majority of CFU-F in adult murine BM (Zhou et al., 2014) . Our data showed that LEPR expression is conserved; i.e., that the majority of human adult CFU-F is contained in the LEPR + fraction ( Figure S2J ). Figure 1D ).
Group
Whereas sorting based on FGFR3 expression did not improve CFU-F enrichment (data not shown), very high CFU-F frequencies were observed when CD271 + cells were sorted according to low/negative CD140a expression (Figure 1E) . Mean CFU-F frequencies in bulk cultures seeded at clonal densities were as high as 20.8 ± 9.6 CFU-F per 100 cells in the CD140a low/À fraction compared with 0.8 ± 1.2 CFU-F per 100 plated CD140a + cells and 0.8 ± 0.8 CFU-F per 100 plated CD271 + cells ( Figure 1E , left graph).
Similar results were obtained by single cell assays and limiting dilution analysis ( Figure 1E , middle and right graphs, respectively). Considering that the high frequency of progenitor activity corresponds well to that reported for other immunophenotypically defined stem cell populations, such as HSCs, lin
low/À cells are likely to represent a (close to) pure population of primary MSCs in human adult BM. Recently, Mabuchi et al., (2013) reported comparable CFU-F frequencies by using a direct two-marker isolation approach (CD271, CD90). However, experiments in their study were performed with femoral bone fragments, which contain only few hematopoietic cells. In contrast, + BM cell populations sorted on CD140a expression. Data are presented as individual data (dots) from bulk sorting (left plot, n = 5-11 independent experiments with at least three replicates for each experiment), and three independent limiting dilution experiments with seven different cell concentrations for each experiment (right plot, each dot in the plot represents the average of the three experiments). Single cell sorting data were calculated from three independent experiment, and data are given as mean ± SD (middle plot). The sorting strategy is illustrated in Figure S3 Figure 2B ). As reported previously (Tormin et al., 2011) , SSEA-4 and GD2 were not detected on primary BM-MSCs ( Figure 2B ), which might be due to differences in experimental protocols. Among lin
expression of pluripotency genes (Nanog, Oct4, Sox2) and cyclin-dependent kinase inhibitor gene p16 was higher in CD140a low/À than in CD140a + cells ( Figure 2C ). Comparable gene expression was observed for differentiation genes (ALPL, PPARg, ACAN), p21, and decoy receptor 2 (DCR2). Figure 2G ). This was not only observed in multiclonal cultures from bulksorted cells, but also in single-cell-derived clones, of which 62%, 31%, and 7% exhibited trilineage, bilineage, and unilineage differentiation potential, respectively. Finally, in vivo differentiation potential was tested by subcutaneous implantation of lin À /CD45 À /CD271 + /CD140a low/À -derived cells into immunodeficient mice. In addition to bone, adipocytes, and stromal tissues, invading hematopoietic cells were clearly identified in the ectopic scaffolds ( Figure 2H) . These results thus demonstrate that CD140a low/À cells have the capacity to generate hematopoietic stroma in vivo, a key property of primary BMMSCs (Sacchetti et al., 2007) .
Hematopoiesis-Supporting Capacity of lin
We have recently shown that primitive BM-MSCs promote the ex vivo expansion of human umbilical cord blood (CB)-derived CD34 + cells (Isern et al., 2013 Figure 3A ). Figure 3D ), which showed a better preservation of the CD34 + phenotype compared with cMSC ( Figure 3E ). Correspondingly,
low/À cells showed high expression of hematopoiesis-supporting genes (VCAM1, SPP1, CXCL12, and angiopoietin 1; Figure 3F) Figure 4 ). CD140a, which is a long-known marker for murine MSCs, has only recently been reported as a positive marker to identify human fetal BM CFU-F-initiating cells (Pinho et al., 2013) . However, adult BM cells are by far the most commonly used MSC source, and our data clearly demonstrate that MSCs are highly enriched within the CD140a low/À population but not in CD140 + cells. This distribution pattern is also observed in older adults, even though CFU-F frequencies in CD140a low/À cells are lower ( Figure S4 ). On the other hand and consistent with previous work (Pinho et al., 2013) , we found that fetal CD140a + cells had an increased CFU-F frequency, clearly contrasting the results in adult BM cells. These data suggest that CD140a expression is progressively downregulated during development, which was also supported by examination of the CD140a expression of murine BM-MSCs at different developmental stages ( Figure S4D ). Platelet-derived growth factor (PDGF) is a key signaling molecule in the complex bone formation process and a powerful mitogen and chemoattractant for MSCs, inducing proliferation as well as affecting directional mobility (Caplan and Correa, 2011) . Increased PDGFR-a signaling in embryos leads to hyperplasia of stromal fibroblasts (Olson and Soriano, 2009 ). The MSC enrichment in the CD140a + fraction during bone development and its progressive downregulation strongly suggest that it might be required for osteoprogenitor activity possibly also under pathological conditions, but our results suggest that this receptor may not necessarily be essential for the HSC niche function of BM-MSCs. In summary, based on comparative gene expression analysis, we could demonstrate that low/negative expression of CD140a identified a close to pure population of the putative stromal stem/progenitor cells in human adult BM, which is likely to be a critical first step toward a better functional characterization of these important constituents of the hematopoietic microenvironment.
EXPERIMENTAL PROCEDURES

BM Mononuclear Cells
A total of 111 BM samples were collected from 87 healthy adult donors (median age, 25 years; range 19-41) plus three additional older donors (52, 56, and 61 years). BM (60 ml) was aspirated from the iliac crest bone of consenting healthy donors. BM aspiration was approved by the local ethics committee. BM-MNCs were isolated by density gradient centrifugation (LSM 1077 Lymphocyte; PAA) with or without prior incubation with RosetteSep Human MSC Enrichment Cocktail (StemCell Technologies) for lineage depletion (CD3, CD14, CD19, CD38, CD66b, glycophorin A). The preparation of fetal BM cells is described in Figure S3 .
Generation of Cultured MSCs and CFU-F Assays
Sorted BM-MNCs were cultured in standard MSC culture medium (NH Expansion Medium; Miltenyi Biosciences) and passaged as described (Tormin et al., 2011) . CFU-F assays were performed as before (Tormin et al., 2011) ; a detailed description is provided in the Supplemental Experimental Procedures.
Microarray Expression Analysis
RNA from sorted cell populations was isolated, amplified, and analyzed for gene expression microarray analysis using Illumina Human HT-12 expression v4 BeadChips (Illumina). Detailed experimental procedures and data analysis are described in the Supplemental Experimental Procedures. + cells into NSG mice. CB blood CD34 + cells were cocultured for 1 week with or without feeder cells in cytokine-supplemented medium (SCF, TPO, Flt3L at 25 ng/ml). Engraftment was assessed after 8, 12, and 16 weeks using human-specific CD45 antibodies (A and B) and CD15/CD33/CD66 and CD19 antibodies (C). Representative FACS plots are shown. Data in (B) represent the mean ± SD of a total of four to six mice per time point. 
Fluorescence-Activated Cell Sorting
In Vitro Differentiation Assays
Cultured MSCs were differentiated toward the adipogenic, osteoblastic, and chondrogenic lineages as described previously (Tormin et al., 2011) . Briefly, cells were cultured for 14 days in AdipoDiff medium (Miltenyi) and were stained with Oil red O (Sigma). For osteogenic differentiation, cells were cultured in osteogenesis induction medium (see the Supplemental Experimental Procedures) for 21 days and stained with alizarin red (Sigma). Chondrogenic differentiation was induced by culturing cell pellets (2.5 3 10 5 cells/pellet) for 56 days in chondrogenesisinduction medium (see the Supplemental Experimental Procedures). Cryosections of paraformaldehyde-fixed pellets were stained against aggrecan as described previously (Tormin et al., 2011 Implants were removed after 8 weeks, fixed, decalcified, and paraffin embedded. Sections were stained with hematoxylin/eosin and analyzed as described (Abdallah et al., 2008) . All animal procedures were approved by the local ethical committees on animal experiments.
CD34 + Cells Isolation from CB
Umbilical CB samples were obtained from full-term, normal deliveries with informed consent in accordance with institutional guidelines and as approved by the local ethical committee. Isolation and enrichment of CD34 + cells from CB samples were carried out on mononuclear cells by magnetic-activated cells sorting (Miltenyi) according to manufacturer's instructions. Cells were subsequently frozen in freezing buffer (90% fetal calf serum plus 10% DMSO).
Coculture of CB CD34 + Cells with BM-MSCs
Different FACS-sorted primary BM stromal cell populations or culture-derived MSCs (third or fourth passage) were plated into 96-well plates at 1,000 cells per well and cultured in nonhematopoietic medium for 7-10 days. Then medium was removed, and 5,000 CB CD34 + cells were added onto the adherent stromal cells in serum-free expansion medium (StemCell Technologies) supplemented with 25 or 100 ng/ml of stem cell factor (SCF), thrombopoietin (TPO), and FLT3-ligand (FLT3L) (all from Peprotech). Cells were harvested, counted, and analyzed after 1 week of coculture.
In Vivo HSC Repopulation Assay
Eight-to 12-week old female NOD.Cg-Prkdc control. The culture equivalent of 50,000 input CD34 + cells was intravenously injected, and human engraftment was assessed 8, 12, and 16 weeks after transplantation by flow cytometry (human-specific antibodies against CD45, CD15/CD33/CD66b, and CD19). All animal experiments were approved by local animal ethics committee, Lund University.
Statistical Analysis
Data are expressed as mean ± SD. For a comparison of two samples, the two-tailed Student's t test was used. For multiple comparisons, data were analyzed by one-way ANOVA using the Bonferroni posttest. Differences are reported significant when p < 0.05.
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